Abstract
Natural polyamines have numerous biological activities. Several studies have reported their beneficial role in bone metabolism, but their mode of action is not fully understood. Bone diseases such as osteoporosis, which is characterized by impaired bone structure and low bone mass, are caused by an increased number of osteoclasts and/or overactivation of osteoclastogenesis. Osteoclast differentiation is a multi-complex procedure involving the following sequential steps: differentiation–migration–fusion–resorption. In this study, we found that putrescine, spermidine or spermine inhibited the RANKL-mediated migration of preosteoclasts. Furthermore, the RANKL-mediated activation of the Src-PYK2 signaling axis and of transcription factors such as NF-κB and NFATc1 was prevented by each polyamine. Anti-osteoclastogenic and anti-migration activities of polyamines were confirmed by evaluating their potential to downregulate the mRNA expression levels of osteoclastogenesis-related genes such as OSCAR, TRAP, cathepsin K and c-Src, and genes related to fusion and/or migration of preosteoclasts. Moreover, ATP-mediated elevation of cytosolic free Ca2+ concentration ([Ca2+]i) was strongly inhibited by each polyamine, indicating the involvement of [Ca2+]i in the anti-fusion activities of polyamines. In conclusion, polyamines could exhibit anti-osteoclastogenic activity by inhibiting the migration of preosteoclasts via the Ca2+-PYK2-Src-NFATc1 signaling axis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Bone is dynamically maintained by the functional balance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation (Boyle et al. 2003). However, an imbalance caused by the increased activity and/or number of osteoclasts leads to skeletal diseases characterized by low bone density, which is the major cause of bone fracture. Therefore, much attention has been focused on the pharmacologic control of osteoclasts for the treatment of osteoclast-related bone disorders including osteoporosis and arthritis (Broadhead et al. 2011; Kim and Moon 2013).
The representative natural polyamines, putrescine, spermidine, and spermine, (Fig. 1a), exhibit several biological activities in terms of cell growth, proliferation, and differentiation by regulating gene expression and intracellular signaling (Li et al. 2001; Zhao et al. 2012; Igarashi and Kashiwagi 2010; Lefevre et al. 2011). Focusing on the pharmacological properties of polyamines in the musculoskeletal system, spermine has been shown to have pharmacological properties in cartilage and bone destruction in the joints of rats with collagen-induced arthritis (Iezaki et al. 2012). Furthermore, both spermidine and spermine have been shown to prevent bone loss in ovariectomized mice through inhibition of maturation and differentiation of osteoclasts (Yamamoto et al. 2012). Although the clinical benefits of natural polyamines for bone metabolism have been reported in several studies, the mode of action of their anti-osteoclastogenic activity has not been fully elucidated yet. Therefore, in this study, we have evaluated when and how polyamines can inhibit osteoclast differentiation using a bone marrow macrophages (BMMs)-based osteoclastogenesis model.
Materials and methods
Materials
Putrescine, spermidine, and spermine were purchased from Sigma-Aldrich (MO, USA).
Ethics statement
This study was carried out in strict accordance with the recommendations of the Standard Protocol for Animal Study of Korea Research Institute of Chemical Technology (KRICT; Permit No. 2012-7D-02-01). The protocol (ID No. 7D-M1) was approved by the Institutional Animal Care and Use Committee of KRICT (IACUC-KRICT). All efforts were made to minimize suffering, animal number and stress/discomfort.
Osteoclast differentiation
After cervical dislocation, bone marrow cells were obtained from 5-week-old male ICR mice (Damool Science, Daejeon, Korea) by flushing femurs and tibias with α-MEM supplemented with antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin; Invitrogen, NY, USA). Bone marrow cells were cultured for 1 day on a culture dish in α-MEM supplemented with 10 % fetal bovine serum (FBS; Invitrogen, NY, USA) and mouse macrophage-colony stimulating factor (10 ng/ml M-CSF; R&D Systems, MN, USA). Non-adherent bone marrow cells were plated on a Petri dish and cultured for 3 days in the presence of M-CSF (30 ng/ml). After non-adherent cells were washed out, adherent cells were used as bone marrow-derived macrophages (BMMs). For osteoclastogenesis, BMMs (1 × 104 cells/well in a 96-well plate or 3 × 105 cells/well in a 6-well plate) were cultured in the presence of M-CSF (30 ng/ml) and mouse soluble receptor activator of nuclear factor-κB ligand (10 ng/ml RANKL; R&D Systems, MN, USA) for 4 days. For preosteoclasts, BMMs were cultured with M-CSF (30 ng/ml) and RANKL (10 ng/ml) for 3 days.
Cytotoxicity assay
BMMs were plated at a density of 1 × 104 cells/well on a 96-well plate in triplicate. After treatment with M-CSF (30 ng/ml) and each polyamine, cells were cultured for 3 days. Then, cell viability was measured by CCK-8 assay kit (Dojindo Molecular Technologies, ML, Japan) according to the manufacturer’s protocol.
Tartrate-resistant acid phosphatase (TRAP) staining and activity assay
Cells were fixed with 3.7 % formaldehyde for 5 min, permeabilized with 0.1 % Triton X-100 for 5 min, and stained with the Leukocyte Acid Phosphatase Kit 387-A (Sigma-Aldrich, MO, USA). TRAP-positive multinuclear cells with three or more nuclei were counted as osteoclasts. To measure TRAP activity, cells were treated with TRAP buffer (100 mM sodium citrate, pH 5.0, 50 mM sodium tartrate) including 3 mM p-nitrophenyl phosphate (Sigma-Aldrich) at 37 °C for 5 min. Reaction mixtures were transferred to a new plate containing an equal volume of 0.1 N NaOH, and optical density values were determined at 405 nm in Wallac EnVision microplate reader (Perkin Elmer, MA, USA).
Cell migration assay
The ability of preosteoclasts to pass through a gelatin-coated membrane was measured in a Boyden chamber with modifications (Kimachi et al. 2011; Brazier et al. 2009). Briefly, the preosteoclasts derived from BMMs cultured with RANKL (10 ng/ml) and M-CSF (30 ng/ml) for 3 days were detached with scrapper (Corning, NY), resuspended, and incubated with each polyamine in α-MEM containing 0.1 % FBS, M-CSF (30 ng/ml) and RANKL (10 ng/ml) for 2 h. During incubation, α-MEM (30 μL) containing 10 % FBS and each polyamine was added to the bottom of a Boyden chamber, which was then placed over the gelatin-coated membrane filter, the silicone gasket, and the top chamber. Then, polyamine-treated preosteoclasts (2 × 104 cells/50 μL) were added to the top chamber, followed by incubation at 37 °C in 5 % CO2 for 18 h. At the end of the incubation, the cells in the upper surface of the membrane were carefully removed with a cotton swab, and preosteoclasts that had migrated across the gelatin to the lower surface of the membrane were fixed and stained with Diff-Quick (Dade Behring, NJ). The density of migrated preosteoclasts on the lower surface of the membrane was calculated with NIH ImageJ 1.43u software. The numbers of migrated cells were counted in random areas of the membrane.
Real-time PCR
Real-time PCR was performed as previously described (Choi et al. 2012, 2013). Primers were chosen with the online Primer3 design program (Rozen and Skaletsky 2000). The primer sets used in this study are shown in Table 1. Briefly, total RNA was isolated with TRIzol reagent, and first-strand cDNA was synthesized with the Omniscript RT kit (Qiagen, Germany) according to the manufacturer’s protocol. SYBR green-based QPCR was performed with the Stratagene Mx3000P Real-Time PCR system and Brilliant SYBR Green Master Mix (Stratagene, CA). All reactions were run in triplicate, and data were analyzed by the 2−ΔΔCT method (Livak and Schmittgen 2001). Hypoxanthine phosphoribosyltransferase 1 (HPRT1) was used as an internal standard gene. The statistical significance was determined by Student’s t test with HPRT1-normalized 2−ΔΔCT values; differences were considered significant at p < 0.05.
Western blot and densitometric analysis
Western blot analysis was performed as described previously (Choi et al. 2012, 2013). Briefly, cells were washed, lysed, and centrifuged at 10,000×g for 15 min. Cytoplasmic or nuclear protein fractions were prepared using a NucBuster Protein Extraction kit (Novagen, Germany) according to the manufacturer’s protocol. After protein quantification of the supernatants by the BCA protein assay (Pierce, IL), proteins were denatured, separated on SDS-PAGE gels, and transferred onto PVDF membranes (Millipore, CA, USA). Expression of each protein was detected using the indicated primary antibody. Antibodies against p-Src and Src were purchased from Cell Signaling Technology (MA, USA). Antibodies against p-PYK2, PYK2, NF-κB/p65, NFATc1, and Actin were purchased from Santa Cruz Biotechnology (CA, USA). Antibody against Lamin B1 was obtained from AbFrontier (Seoul, Korea). Actin and Lamin B1 were used for the loading control of cytosol and nuclear proteins, respectively. After incubation with antibody, the membranes were developed using SuperSignal West Femto Maximum Sensitivity Substrate (Pierce, IL, USA) and visualized with the LAS-3000 luminescent image analyzer (Fuji Photo Film Co., Ltd., Tokyo, Japan). Each experiment was repeated at least three times and the data shown here represent them. ImageJ software-based quantification of the detected bands was performed, and the relative, normalized ratios between the density of phosphorylated form and that of the protein itself were presented. Also, the relative, normalized ratios of cytosolic protein to actin or nuclear protein to lamin B1 were also presented.
Intracellular Ca2+ measurement
Intracellular Ca2+ was measured using Fluo-4 NW Calcium assay kits (Molecular Probes, OR, USA). BMMs were seeded at a density of 2.5 × 104 cells in a 96-well assay plate (black with clear-bottom tissue culture plate; COSTAR, NY, USA) with α-MEM medium containing 10 % FBS in the presence of RANKL (10 ng/ml) and M-CSF (30 ng/ml) for 48 h. The media were then removed from the wells and replaced with 90 μL of assay buffer containing Fluo-4 NW and Probenecid solution for 45 min. While the fluorescence was measured by FlexStation II (Molecular Devices, USA), the assay buffer (10 μL) containing adenosine triphosphate (ATP) with/without each polyamine was applied into the 96-well plates. The excitation/emission/cutoff filter pair (485/525/515 nm) was used to measure signals every 2 s for 100 s. Of the total duration (100 s), co-treatment of ATP and/or polyamines was performed for 20 s.
Statistical analysis
All quantitative values are presented as mean ± SD. Statistical differences were analyzed using Student’s t test. A value of p < 0.05 was considered to be significant.
Result
Polyamines inhibit RANKL-induced osteoclast differentiation
First of all, the effect of polyamine on the survival of BMMs was evaluated. When BMMs were cultured with polyamines in the presence of M-CSF for 3 days, there was no cytotoxicity by the polyamines (Fig. 1b). In the same concentration range, the effect of polyamines on RANKL-induced osteoclast differentiation was evaluated. TRAP-positive multinucleated cells (MNCs) were observed in RANKL-treated BMMs, but polyamines inhibited the RANKL-induced formation of MNCs (Fig. 1c). Consistent with these data, the number of TRAP-positive MNCs (multinucleated cells ≥3) was significantly inhibited by polyamines in a dose-dependent manner (Fig. 1d). Compared to putrescine, both spermidine and spermine strongly suppressed the RANKL-induced formation of MNCs.
Polyamines inhibit RANKL-induced fusion and migration of preosteoclasts
Next, the effect of polyamines on the fusion of mononuclear preosteoclasts was evaluated. When preosteoclasts that were differentiated from BMMs by treatment with RANKL and M-CSF for 3 days were treated with polyamines, the polyamines significantly suppressed the formation of TRAP-positive MNCs in a dose-dependent manner (Fig. 1e, f). Moreover, cell migration assay revealed the inhibitory effect of polyamines on the migration of preosteoclasts (Fig. 1g, h); consistent with the inhibitory effect of polyamines on the fusion of preosteoclasts, polyamines significantly and dose-dependently prevented the migration of preosteoclasts.
Polyamines inhibit RANKL-induced activation of Src, PYK2, NF-κB, and NFATc1 in preosteoclasts
To elucidate how polyamines inhibit the migration of preosteoclasts, we further investigated the effect of polyamines on the activation of migration-related signaling molecules. BMMs differentiated into preosteoclasts for 3 days were treated with polyamines. As shown in Fig. 2a, RANKL-induced phosphorylation of Src at Y416 and proline-rich tyrosine kinase 2 (PYK2) at Y402 were prevented by the pre-treatment with polyamines. Furthermore, we investigated the effect of polyamines on the translocation of osteoclast-specific transcription factors in preosteoclasts. The RANKL-induced nuclear translocation of NF-κB/p65 and nuclear factor of activated T cells (NFATc1) was strongly prevented by spermidine and spermine, and weakly prevented by putrescine. The inhibitory effects of these polyamines on the RANKL-induced NF-κB activation (Fig. S1) and nuclear translocation of NFATc1 (Fig. S2) were confirmed by measuring the NF-κB reporter luciferase activity and by analyzing the immunofluorescence staining of NFATc1, respectively. The degradation of cytosolic NFATc1 by spermine was also observed. Additionally, polyamines significantly inhibited the mRNA expression of NFATc1 in preosteoclasts (Fig. 2b).
Polyamines inhibit the RANKL-induced mRNA expression of osteoclastogenesis-related genes and fusion and/or migration-related genes in preosteoclasts
We next explored the effect of polyamines on the RANKL-induced mRNA expression of osteoclastogenesis-related genes as well as fusion and migration-related genes. As shown in Fig. 3, the mRNA expression of these genes was significantly inhibited by polyamines.
Polyamines inhibit the ATP-mediated induction of [Ca2+]i in preosteoclasts
Since polyamines have been reported to block and/or modulate a number of types of ion channel (Williams 1997), we evaluated the effect of polyamines on ATP-induced intracellular Ca2+ changes in preosteoclasts. ATP was used for the induction of [Ca2+]i in preosteoclasts, because it is known to induce a Ca2+ influx across the cell membrane in osteoclasts (Yu and Ferrier 1994), but the Ca2+ oscillation was not changed by additional treatment of RANKL in the RANKL-induced preosteoclasts (Fig. S3). In preosteoclasts derived from BMMs by RANKL and M-CSF for 2 days, the induction of cytosolic free Ca2+ concentration ([Ca2+]i) by ATP was observed, but its induction was strongly prevented by polyamines as shown in Fig. 4. Rather, the co-treatment of preosteoclasts with polyamines and ATP decreased the level of [Ca2+]i.
Discussion
Osteoclastogenesis is a multi-complex process including the sequential steps of differentiation–migration–fusion–resorption. M-CSF and RANKL trigger the differentiation of osteoclast precursors into mononuclear osteoclasts (preosteoclasts) and induce their migration for attachment onto the bone surface. They then fuse with each other to form giant multinucleated osteoclasts that consequently mediate bone resorption (Yavropoulou and Yovos 2008; Kikuta and Ishii 2013).
Recently, naturally occurring polyamines have been reported to significantly inhibit in vitro osteoclast differentiation and prevent in vivo bone loss in ovariectomized mice (Yamamoto et al. 2012). Furthermore, when RAW264.7 cells were cultured with either spermidine or spermine at 1 μM in the presence of RANKL for 4 days, both polyamines significantly inhibited the formation of TRAP-positive multinucleated osteoclasts without affecting cell viability. Consistent with those results, we also found anti-osteoclastogenic activity of both spermidine and spermine at non-cytotoxic dosages in BMMs-based osteoclastogenesis model. Putrescine also significantly inhibited the RANKL-induced formation of multinucleated osteoclasts when it was co-treated with RANKL, even though its anti-osteoclastogenic activity was weak.
Additionally, the polyamines tested in this study significantly inhibited osteoclast differentiation in preosteoclasts derived from BMMs by RANKL treatment for 3 days. In RAW264.7 cells, both spermidine and spermine failed to inhibit osteoclast differentiation when added 1 day after RANKL-induced osteoclast differentiation (Yamamoto et al. 2012). This difference might be due to the presence of M-CSF in the model. M-CSF can stimulate osteoclast formation by enhancing the survival and fusion of preosteoclasts derived from bone marrow cells (Takami et al. 1999), but it was not used for differentiation of RAW264.7 cells into osteoclast-like cells. That is why both spermidine and spermine failed to inhibit osteoclast differentiation when added 1 day after RANKL treatment (Yamamoto et al. 2012).
Furthermore, M-CSF has been known to induce the migration of osteoclasts (Owens and Chambers 1993; Fuller et al. 1993) and here we also found anti-migration activity of polyamines in preosteoclasts, suggesting that the anti-osteoclastogenic activity of polyamines could be due to their potential to inhibit the migration of preosteoclasts before their fusion. Furthermore, considering that there were no differences in the adhesion of preosteoclasts treated with polyamines, the anti-fusion activity of polyamines in preosteoclasts could not be adhesion dependent, but rather is associated with the change of intracellular signaling networks related to fusion and/or migration of preosteoclasts.
The Src-PYK2 signaling axis is related to osteoclast migration; the engagement of PYK2 with αvβ3 integrin leads to Src-dependent tyrosine phosphorylation (Y402) and activation of PYK2 (Lakkakorpi et al. 2003; Duong et al. 1998). The involvement of Src in osteoclast function has been validated by studying osteopetrotic Src-deficient mice (Soriano et al. 1991) and, interestingly, M-CSF-mediated activation of c-Src by phosphorylation of Y416 has been shown to induce osteoclast migration (Zou et al. 2007, 2008). In this study, the RANKL-mediated phosphorylations of Src (Y416) and PYK2 (Y402) in the presence of M-CSF were prevented by pre-treatment with polyamines, suggesting that the anti-fusion activity of polyamines involves preventing RANKL-induced activation of the Src-PYK2 signaling cascade.
RANKL-induced signaling cascades require the sequential expression and activity of transcription factors such as NF-κB and NFATc1 to complete the osteoclast differentiation. Recently, spermidine and spermine have been shown to inhibit the transcriptional activity of NF-κB, but not NFATc1, in RAW264.7 cells (Yamamoto et al. 2012). In this study, the inhibitory effects of polyamines on the activity of NF-κB was confirmed and, furthermore, we found that the RANKL-induced nuclear translocation of NFATc1 as well as NF-κB p65 subunit was inhibited in preosteoclasts derived from BMMs by polyamines. NF-κB/p65 has been reported to enhance osteoclast differentiation (Vaira et al. 2008) and control cell survival during a critical stage of commitment to the osteoclast lineage (Novack 2011). Additionally, these polyamines significantly inhibited the mRNA expression of NFATc1 in preosteoclasts. Considering that NFATc1 has been recognized as a master regulator for osteoclastogenesis as well as osteoclast migration (Zhao et al. 2010), our results suggest that the inhibitory effects of polyamines on the expression and nuclear translocation of NFATc1 could cause their anti-fusion activities by regulating the expression of genes related to fusion and/or migration of preosteoclasts.
Anti-osteoclastogenic and anti-fusion activities of polyamines were confirmed by evaluating their potential to downregulate the mRNA expression levels of osteoclastogenesis-related molecules such as osteoclast-associated receptor (OSCAR), TRAP, cathepsin K and c-Src, and genes related to fusion and/or migration of preosteoclasts and/or osteoclasts. Dendrite cell-specific transmembrane protein (DC-STAMP) and d2 isoform of vacuolar (H+) ATPase V0 domain (ATP6vOd2) have been shown to contain multiple NFATc1 binding sites in their promoter regions (Kim et al. 2008), and both have been reported to play a role in the fusion of preosteoclasts (Kim et al. 2008; Song et al. 2009). Furthermore, overexpression of DC-STAMP and ATP6v0d2 rescued osteoclast fusion, even in conditions of reduced NFATc1 activity (Kim et al. 2008). Integrins and the p85α subunit of phosphatidylinositol 3-kinase (PI3K) are involved in the migration of preosteoclasts (Nakamura et al. 1999; Munugalavadla et al. 2008). In particular, deficiency of p85α osteoclasts leads to a significant reduction in the expression of several genes including TRAP, cathepsin K, and β3 integrin (Munugalavadla et al. 2008). Additionally, the activation of calcium sensing receptor (CaR) produces an extracellular Ca2+ concentration gradient-dependent chemoattractant effect in the osteoclast precursors (Boudot et al. 2010).
In addition to downregulating CaR, the polyamines exhibit inhibitory effects on calcium mobilization in the bone, leading to further questions about whether calcium could be involved in the anti-fusion activities of polyamine (Ljunggren et al. 1991; Stern et al. 1991). Recently, elevation of cytosolic free Ca2+ concentration ([Ca2+]i) has been observed in the migrating osteoclasts for the uropod that precede retraction, suggesting that elevation of [Ca2+]i is required for osteoclast migration (Wheal et al. 2014). They also confirmed the involvement of [Ca2+]i in the osteoclast migration by a pharmacologic study; the Ca2+ chelator BAPTA abolished uropod retraction, and ionomycin-induced elevation of [Ca2+]i initiated prompt uropod retraction. Here, we found that ATP-mediated elevation of [Ca2+]i was strongly inhibited by treatment with each polyamine. Since ATP is known to induce a Ca2+ influx across the cell membrane in osteoclasts (Yu and Ferrier 1994), the inhibitory effects of polyamines on the ATP-induced increase of [Ca2+]i indicated the involvement of [Ca2+]i in the anti-fusion activities of polyamines.
Furthermore, the Ca2+ pathway may be correlated with the activity of NFATc1. Calcium oscillation can lead to the calcineurin-mediated activation of NFATc1 through autoamplification of NFATc1 (Negishi-Koga and Takayanagi 2009; Takayanagi 2007), and several calcineurin inhibitors have been shown to suppress osteoclastogenesis via inhibition of the Ca2+-NFATc1 pathway (Negishi-Koga and Takayanagi 2009). These results suggest that the mechanism of action for polyamines to abolish NFATc1 activity involves the blockade of Ca2+-mediated signaling.
In conclusion, polyamines may exhibit anti-osteoclastogenic potential to inhibit the migration of preosteoclasts in the fusion step via the Ca2+-PYK2-Src-NFATc1 signaling axis. Similarly, the phenotype of PYK2-deficient mice has macrophages that exhibit impaired migration as a result of cytoskeleton abnormalities induced by diminished Ca2+ mobilization and reduced activation of PI3K (Matsui et al. 2007). In the clinical aspect, targeting the migration of preosteoclasts might represent a new therapeutic approach for treating osteoclast-related disorders including osteoporosis, rheumatoid arthritis, and bone cancer.
References
Boudot C, Saidak Z, Boulanouar AK, Petit L, Gouilleux F, Massy Z, Brazier M, Mentaverri R, Kamel S (2010) Implication of the calcium sensing receptor and the phosphoinositide 3-kinase/Akt pathway in the extracellular calcium-mediated migration of RAW 264.7 osteoclast precursor cells. Bone 46(5):1416–1423. doi:10.1016/j.bone.2010.01.383
Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423(6937):337–342. doi:10.1038/nature01658
Brazier H, Pawlak G, Vives V, Blangy A (2009) The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration. Int J Biochem Cell Biol 41(6):1391–1401. doi:10.1016/j.biocel.2008.12.007
Broadhead ML, Clark JC, Dass CR, Choong PF, Myers DE (2011) Therapeutic targeting of osteoclast function and pathways. Expert Opin Ther Targets 15(2):169–181. doi:10.1517/14728222.2011.546351
Choi SW, Moon SH, Yang HJ, Kwon DY, Son YJ, Yu R, Kim YS, Kim SI, Chae EJ, Park SJ, Kim SH (2013) Antiresorptive activity of bacillus-fermented antler extracts: inhibition of osteoclast differentiation. Evid Based Complementary Alternat Med 2013:748687. doi:10.1155/2013/748687
Choi SW, Son YJ, Yun JM, Kim SH (2012) Fisetin inhibits osteoclast differentiation via downregulation of p38 and c-Fos-NFATc1 signaling pathways. Evid Based Complementary Alternat Med 2012:810563. doi:10.1155/2012/810563
Duong LT, Lakkakorpi PT, Nakamura I, Machwate M, Nagy RM, Rodan GA (1998) PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. J Clin Invest 102(5):881–892. doi:10.1172/jci3212
Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ (1993) Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178(5):1733–1744
Iezaki T, Hinoi E, Yamamoto T, Ishiura R, Ogawa S, Yoneda Y (2012) Amelioration by the natural polyamine spermine of cartilage and bone destruction in rats with collagen-induced arthritis. J Pharmacol Sci 119(1):107–111
Igarashi K, Kashiwagi K (2010) Modulation of cellular function by polyamines. Int J Biochem Cell Biol 42(1):39–51. doi:10.1016/j.biocel.2009.07.009
Kikuta J, Ishii M (2013) Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases. Rheumatology (Oxford) 52(2):226–234. doi:10.1093/rheumatology/kes259
Kim K, Lee SH, Ha Kim J, Choi Y, Kim N (2008) NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 22(1):176–185
Kim SH, Moon SH (2013) Osteoclast differentiation inhibitors: a patent review (2008–2012). Expert Opin Ther Pat 23(12):1591–1610. doi:10.1517/13543776.2013.842556
Kimachi K, Kajiya H, Nakayama S, Ikebe T, Okabe K (2011) Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis. Naunyn Schmiedeberg Arch Pharmacol 383(3):297–308. doi:10.1007/s00210-010-0596-4
Lakkakorpi PT, Bett AJ, Lipfert L, Rodan GA, le Duong T (2003) PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption. J Biol Chem 278(13):11502–11512. doi:10.1074/jbc.M206579200
Lefevre PL, Palin MF, Murphy BD (2011) Polyamines on the reproductive landscape. Endocr Rev 32(5):694–712. doi:10.1210/er.2011-0012
Li L, Rao JN, Guo X, Liu L, Santora R, Bass BL, Wang JY (2001) Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation. Am J Physiol Cell Physiol 281(3):C941–C953
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402–408. doi:10.1006/meth.2001.1262
Ljunggren O, Fredholm BB, Lerner UH (1991) On the role of polyamines in bone resorption induced by parathyroid hormone. Acta Physiol Scand 142(2):267–273. doi:10.1111/j.1748-1716.1991.tb09156.x
Matsui A, Okigaki M, Amano K, Adachi Y, Jin D, Takai S, Yamashita T, Kawashima S, Kurihara T, Miyazaki M, Tateishi K, Matsunaga S, Katsume A, Honshou S, Takahashi T, Matoba S, Kusaba T, Tatsumi T, Matsubara H (2007) Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase-mediated angiogenic response and vascular function. Circulation 116(9):1041–1051. doi:10.1161/circulationaha.106.645416
Munugalavadla V, Vemula S, Sims EC, Krishnan S, Chen S, Yan J, Li H, Niziolek PJ, Takemoto C, Robling AG, Yang FC, Kapur R (2008) The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration. Mol Cell Biol 28(23):7182–7198. doi:10.1128/mcb.00920-08
Nakamura I, Pilkington MF, Lakkakorpi PT, Lipfert L, Sims SM, Dixon SJ, Rodan GA, Duong LT (1999) Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone. J Cell Sci 112(Pt 22):3985–3993
Negishi-Koga T, Takayanagi H (2009) Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Rev 231(1):241–256. doi:10.1111/j.1600-065X.2009.00821.x
Novack DV (2011) Unique personalities within the NF-kappaB family: distinct functions for p65 and RelB in the osteoclast. Adv Exp Med Biol 691:163–167. doi:10.1007/978-1-4419-6612-4_17
Owens J, Chambers TJ (1993) Macrophage colony-stimulating factor (M-CSF) induces migration in osteoclasts in vitro. Biochem Biophys Res Commun 195(3):1401–1407. doi:10.1006/bbrc.1993.2199
Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365–386
Song I, Kim JH, Kim K, Jin HM, Youn BU, Kim N (2009) Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett 583(14):2435–2440. doi:10.1016/j.febslet.2009.06.047
Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64(4):693–702
Stern PH, Lucas RC, Seidenfeld J (1991) Alpha-difluoromethylornithine inhibits bone resorption in vitro without decreasing beta-glucuronidase release. Mol Pharmacol 39(4):557–562
Takami M, Woo JT, Nagai K (1999) Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production. Cell Tissue Res 298(2):327–334
Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7(4):292–304. doi:10.1038/nri2062
Vaira S, Alhawagri M, Anwisye I, Kitaura H, Faccio R, Novack DV (2008) RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J Clin Investig 118(6):2088–2097. doi:10.1172/jci33392
Wheal BD, Beach RJ, Tanabe N, Dixon SJ, Sims SM (2014) Subcellular elevation of cytosolic free calcium is required for osteoclast migration. J Bone Miner Res 29(3):725–734. doi:10.1002/jbmr.2068
Williams K (1997) Modulation and block of ion channels: a new biology of polyamines. Cell Signal 9(1):1–13
Yamamoto T, Hinoi E, Fujita H, Iezaki T, Takahata Y, Takamori M, Yoneda Y (2012) The natural polyamines spermidine and spermine prevent bone loss through preferential disruption of osteoclastic activation in ovariectomized mice. Br J Pharmacol 166(3):1084–1096. doi:10.1111/j.1476-5381.2012.01856.x
Yavropoulou MP, Yovos JG (2008) Osteoclastogenesis—current knowledge and future perspectives. J Musculoskelet Neuronal Interact 8(3):204–216
Yu H, Ferrier J (1994) Mechanisms of ATP-induced Ca2+ signaling in osteoclasts. Cell Signal 6(8):905–914
Zhao Q, Wang X, Liu Y, He A, Jia R (2010) NFATc1: functions in osteoclasts. Int J Biochem Cell Biol 42(5):576–579. doi:10.1016/j.biocel.2009.12.018
Zhao T, Goh KJ, Ng HH, Vardy LA (2012) A role for polyamine regulators in ESC self-renewal. Cell Cycle 11(24):4517–4523. doi:10.4161/cc.22772
Zou W, Kitaura H, Reeve J, Long F, Tybulewicz VL, Shattil SJ, Ginsberg MH, Ross FP, Teitelbaum SL (2007) Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol 176(6):877–888. doi:10.1083/jcb.200611083
Zou W, Reeve JL, Liu Y, Teitelbaum SL, Ross FP (2008) DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol Cell 31(3):422–431. doi:10.1016/j.molcel.2008.06.023
Acknowledgments
This work was supported by the Korea Research Institute of Chemical Technology project’s grant (SI-1304) and the Inter-ER Cooperation Projects (R0002019) of Korea Institute for Advancement of Technology, which were funded by the Korea Ministry of Knowledge Economy.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yeon, JT., Ryu, B.J., Choi, SW. et al. Natural polyamines inhibit the migration of preosteoclasts by attenuating Ca2+-PYK2-Src-NFATc1 signaling pathways. Amino Acids 46, 2605–2614 (2014). https://doi.org/10.1007/s00726-014-1797-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-014-1797-9